ID: ALA5270736

Max Phase: Preclinical

Molecular Formula: C10H11N3OS

Molecular Weight: 221.28

Associated Items:

Representations

Canonical SMILES:  CC1CN1c1cc(O)c2nc(N)sc2c1

Standard InChI:  InChI=1S/C10H11N3OS/c1-5-4-13(5)6-2-7(14)9-8(3-6)15-10(11)12-9/h2-3,5,14H,4H2,1H3,(H2,11,12)

Standard InChI Key:  PHBIAWCGMOCBGF-UHFFFAOYSA-N

Associated Targets(Human)

Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 221.28Molecular Weight (Monoisotopic): 221.0623AlogP: 1.79#Rotatable Bonds: 1
Polar Surface Area: 62.15Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.74CX Basic pKa: 4.45CX LogP: 2.02CX LogD: 1.84
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.72Np Likeness Score: -0.76

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source